These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

58 related items for PubMed ID: 2953485

  • 1. [Preliminary report on the application of thromboxane B2 radioimmunoassay].
    Wang Z, Huang RS, An Y, Zhu GQ, Hu YH.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1986 Aug; 8(4):320-2. PubMed ID: 2953485
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Significance of thromboxane A2 in myocardial ischemia in patients with coronary artery disease.
    Tada M, Kuzuya T, Inoue M, Kodama K, Fukushima M, Abe H.
    Adv Myocardiol; 1980 Aug; 2():397-405. PubMed ID: 7423053
    [Abstract] [Full Text] [Related]

  • 8. Platelet thromboxane A2 synthesizing capacity is enhanced by fasting but diminished by diabetes mellitus in the rat.
    Jeremy JY, Mikhailidis DP, Thompson CS, Barradas MA, Dandona P.
    Diabetes Res; 1988 Aug; 8(4):177-81. PubMed ID: 3233878
    [Abstract] [Full Text] [Related]

  • 9. [Status of the prostacyclin and thromboxane system, lipid metabolism and lipid peroxidation processes in patients with coronary atherosclerosis].
    Efimov VV, Ladnyĭ AI.
    Vrach Delo; 1986 Apr; (4):37-40. PubMed ID: 3754994
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Radioimmunoassay of thromboxane B2 in the prevention and treatment of the ischemic cerebrovascular diseases.
    Cioffi FA, Salvatore M, Natale M, Saviano D, Martiniello D.
    Acta Neurol (Napoli); 1986 Dec; 8(6):589-601. PubMed ID: 3825614
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Plasma thromboxane B2 levels and atherosclerotic disorders.
    Numano F, Omori K, Nishiyama K, Kishi Y, Shimokado K, Numano F, Yajima M, Maezawa H.
    Paroi Arterielle; 1981 Dec; 7(3):99-105. PubMed ID: 6122194
    [Abstract] [Full Text] [Related]

  • 18. Effect of thromboxane synthetase inhibition on platelet function and morphology during ovine pregnancy-induced hypertension.
    Miller KW, Keith JC.
    Thromb Haemost; 1988 Dec 22; 60(3):365-71. PubMed ID: 3238644
    [Abstract] [Full Text] [Related]

  • 19. Arachidonic acid metabolism and urinary excretion of prostaglandins and thromboxane in rats with experimental diabetes mellitus.
    Quilley J, McGiff JC.
    J Pharmacol Exp Ther; 1985 Jul 22; 234(1):211-6. PubMed ID: 3925127
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.